Search results
Results From The WOW.Com Content Network
He spent 8 years working in Novartis Vaccines, at the time a non-profit division focused on developing vaccines for children and patients around the world and served as the Global Head of Development, Novartis Vaccines in the US between 2012 and 2014 before moving to Sandoz as Global Head of Biopharmaceuticals and Oncology Injectables. [6] [17]
Novartis AG. / 47.5744252; 7.5764914. Pharmaceutical drugs, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health ( list...) Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical ...
vaccines, blood testing. Revenue. $1.921 billion (2005) Number of employees. 5,400 (2005) Website. www.chiron.com. Chiron Corporation ( / ˈkaɪrɒn / KY-ron) [1] was an American multinational biotechnology firm founded in 1981, based in Emeryville, California, that was acquired by Novartis on April 20, 2006.
For premium support please call: 800-290-4726 more ways to reach us
The book addresses misinformation related to vaccination, and asks how vaccine rumors start and why they do not go away. [1] [4] Looking chiefly at high-income countries , the book examines social, political, psychological and cultural factors that make up the various mind-sets to vaccination. [2]
The anti-vax campaign is the latest in a series of pro-American disinformation campaigns that have been exposed over the past few years. While the U.S. government warns about the use of "fake or ...
Mr. Justice Aftab Alam [1] Novartis v. Union of India & Others is a landmark decision by a two-judge bench of the Indian Supreme Court on the issue of whether Novartis could patent Gleevec in India, and was the culmination of a seven-year-long litigation fought by Novartis. The Supreme Court upheld the Indian patent office's rejection of the ...
Novartis today announced positive clinical trial results for its vaccine for the H7N9 avian flu, marking the first major step made by a large pharmaceutical company in treating the virus. There ...